F32 - Evolve with the Times (In Range)

Time in Range and CGM data continue to evolve as informative and actionable metrics in diabetes management. This session will explore why Time in Range is an important complement to A1c and the growing scientific support behind the metric. The presenter discusses Time in Range awareness and adoption among healthcare professionals as well as patient-reported outcomes from adopting the metric. This presentation will also provide information on the new international consensus on CGM metrics for clinical trials. Finally, there will be further discussion on the Time in Range Coalition’s efforts to establish Time in Range as a clinical endpoint and how that will impact clinicians and people with diabetes in the future.